Fidelity International’s Moderna MRNA Stock Holding History

Fidelity International’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+3,641	New	+$188K	﹤0.01%	987
2025 Q4	–	Sell	-27,815	Closed	-$718K	–	1055
2025 Q3	$718K	Buy	+27,815	New	+$776K	﹤0.01%	805
2024 Q4	–	Sell	-8,889	Closed	-$594K	–	965
2024 Q3	$594K	Buy	8,889 +8,759	+6,738%	+$804K	﹤0.01%	761
2024 Q2	$15.4K	Buy	+130	New	+$16.5K	﹤0.01%	886
2019 Q2	–	Sell	-1,616,898	Closed	-$32.9M	–	946
2019 Q1	$32.9M	Buy	1,616,898 +540,754	+50%	+$10M	0.05%	298
2018 Q4	$16.4M	Buy	+1,076,144	New	+$17.7M	0.03%	374

Other funds holding MRNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity International's MRNA Position: Q2 2026 in Review

Fidelity International opened a new position in Moderna (MRNA) in Q2 2026: 3,641 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #987 among its holdings. This is a return to the name: Fidelity International previously reported a position in MRNA as recently as Q3 2025.

Fidelity International first reported a position in MRNA in Q4 2018 and has held it in 6 quarters since. The position peaked at $32.9M in Q1 2019. 629 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Fidelity International held 3,641 shares of Moderna worth $255K as of Q2 2026.
Moderna was a new Fidelity International position in Q2 2026.
Moderna made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #987 holding.
Fidelity International first reported a position in Moderna in Q4 2018 and has held it in 6 quarters since.
Fidelity International's Moderna position peaked at $32.9M in Q1 2019.
629 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.